Neovasc Inc. Long-term assets (Other)

Long-term assets (Other) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.


Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending March 31, 2022 was $481 Thousand (a 2.36% increase compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) decreased by -0.58%
  • Annual Long-term assets (Other) for 2021 was $470 Thousand (a -0.15% decrease from previous year)
  • Annual Long-term assets (Other) for 2020 was $471 Thousand (a 1.64% increase from previous year)
  • Annual Long-term assets (Other) for 2019 was $463 Thousand (a 5.28% increase from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of Neovasc Inc.

Most recent Long-term assets (Other)of NVCN including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of Neovasc Inc.

Neovasc Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.48
2021 $0.47 $0.48 $0.48 $0.48 $0.47
2020 $0.47 $0.45 $0.44 $0.42 $0.47
2019 $0.46 $0.45 $0.46 $0.45 $0.46
2018 $0.44 $0.46 $0.46 $0.47 $0.44
2017 $0.48 $0.48 $0.46 $0.45 $0.48
2016 $0.45 $0.45
2012 $0.04 $0.03
2011 $0.04 $0.04

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.